Single cell RNA-sequencing of human precision-cut lung slices: A novel approach to study the effect of vaping and viral infection on lung health
Innate Immunity · 2023
DOI: 10.1177/17534259231181029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innate Immunity, 2023. Verfasst von Taylor Crue und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Hauptthemen laut MEDLINE: Lung Injury, Vaping, Electronic Nicotine Delivery Systems, Virus Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Vaping is an increasing health threat in the US and worldwide. The damaging impact of vaping on the human distal lung has been highlighted by the recent epidemic of electronic cigarette or vaping use-associated lung injury (EVALI). The pathogenesis of EVALI remains incompletely understood, due to a paucity of models that recapitulate the structural and functional complexity of the human distal lung and the still poorly defined culprit exposures to vaping products and respiratory viral infections. Our aim was to establish the feasibility of using single cell RNA-sequencing (scRNA-seq) technology in human precision-cut lung slices (PCLS) as a more physiologically relevant model to better understand how vaping regulates the antiviral and pro-inflammatory response to influenza A virus infection. Normal healthy donor PCLS were treated with vaping extract and influenza A viruses for scRNA-seq analysis. Vaping extract augmented host antiviral and pro-inflammatory responses in structural cells such as lung epithelial cells and fibroblasts, as well as in immune cells such as macrophages and monocytes. Our findings suggest that human distal lung slice model is useful to study the heterogeneous responses of immune and structural cells under EVALI conditions, such as vaping and respiratory viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
- Singulomics Corporation, Bronx, NY, USA.
- Department of Medicine, National Jewish Health, Denver, CO, USA.
ORCID-Profile: Hong Wei Chu
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Crue, T., Lee, G. Y., Peng, J. Y., Schaunaman, N., Agraval, H., Day, B. J., Dimasuay, K. G., Cervantes, D., Nouri, H., Nichols, T., Hartsoe, P., Numata, M., Petrache, I., & Chu, H. W. (2023). Single cell RNA-sequencing of human precision-cut lung slices: A novel approach to study the effect of vaping and viral infection on lung health. Innate Immunity. https://doi.org/10.1177/17534259231181029
Vancouver
Crue T, Lee GY, Peng JY, Schaunaman N, Agraval H, Day BJ, et al. Single cell RNA-sequencing of human precision-cut lung slices: A novel approach to study the effect of vaping and viral infection on lung health. Innate Immunity. 2023. doi:10.1177/17534259231181029
BibTeX
@article{Crue2023,
author = {Crue, Taylor and Lee, Grace Yihua and Peng, Joyce Yao-Chun and Schaunaman, Niccolette and Agraval, Hina and Day, Brian J and Dimasuay, Kris Genelyn and Cervantes, Diana and Nouri, Hamid and Nichols, Taylor and Hartsoe, Paige and Numata, Mari and Petrache, Irina and Chu, Hong Wei},
title = {Single cell RNA-sequencing of human precision-cut lung slices: A novel approach to study the effect of vaping and viral infection on lung health},
journal = {Innate Immunity},
year = {2023},
doi = {10.1177/17534259231181029}
}
EUVIMED